Q2 2026 13F · SEC CIK 1608126
Finepoint Capital LP
Hedge fundFiled 2026-08-13 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $461.0M
- Reported positions
- 6
- Top holdings a year, 3 yrs
- +15.4%
- Assets under management
- $5.0B
Finepoint Capital LP is a hedge fund that reported 6 positions worth $461.0M in its Q2 2026 13F, filed 2026-08-13. Its largest holdings were Qxo Inc (QXO, 67.9%), Rxo Inc (RXO, 32.0%), Aleanna Inc (0.0%). A portfolio copying its top holdings returned 15.4% a year over the last 3 years, against 20.4% for the S&P 500.
Finepoint Capital LP holdings all 6 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
| Stock | % of 13F value | Share change | Reported value |
|---|---|---|---|
| QXOQxo Inc | 67.9% | +30.7% | $313.0M |
| RXORxo Inc | 32.0% | -46.8% | $147.8M |
| 01444V111Aleanna Inc | 0.0% | +0.0% | $147K |
| ANNAAleanna Inc | 0.0% | +0.0% | $80K |
| MNYWWMoneyhero Limited | 0.0% | +0.0% | $37K |
| 320703408Calidi Biotherapeutics Inc | 0.0% | +0.0% | $177.00 |
What Finepoint Capital LP bought and sold in Q2 2026, against Q1 2026.
New positions
No new positions among the largest holdings.
Added to
- QXO Qxo Inc+30.7% shares
Reduced
- RXO Rxo Inc-46.8% shares
Sold out
Nothing sold out.
Share counts compared with the Q1 2026 13F; a split also changes share counts.
How the holdings did against the S&P 500.
- 1 year
- -3.6% /yr
- S&P 500 +20.1%
- 3 years
- +15.4% /yr
- S&P 500 +20.4%
- 5 years
- +7.0% /yr
- S&P 500 +11.6%
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $461.0M | 6 |
| Q1 2026 | $417.1M | 6 |
| Q4 2025 | $532.8M | 7 |
| Q3 2025 | $543.0M | 7 |
| Q2 2025 | $504.3M | 8 |
| Q1 2025 | $592.8M | 23 |
| Q4 2024 | $866.9M | 24 |
| Q3 2024 | $822.3M | 24 |
| Q2 2024 | $352.3M | 25 |
| Q1 2024 | $376.5M | 25 |
| Q4 2023 | $289.1M | 26 |
| Q3 2023 | $200.8M | 28 |
Questions about Finepoint Capital LP's portfolio
What stocks does Finepoint Capital LP own?
Finepoint Capital LP's latest 13F, for Q2 2026 and filed Aug 13, 2026, lists 6 positions worth $461.0M. The largest are Qxo Inc (QXO) at 67.9%, Rxo Inc (RXO) at 32.0%, Aleanna Inc at 0.0%, Aleanna Inc (ANNA) at 0.0% and Moneyhero Limited (MNYWW) at 0.0%.
What did Finepoint Capital LP buy last quarter?
In Q2 2026, Finepoint Capital LP added Qxo Inc (QXO) (+30.7% shares), compared with its Q1 2026 filing.
What did Finepoint Capital LP sell last quarter?
In Q2 2026, Finepoint Capital LP Rxo Inc (RXO) (-46.8% shares), compared with its Q1 2026 filing.
How has Finepoint Capital LP's portfolio performed?
A portfolio copying Finepoint Capital LP's 20 largest 13F holdings each quarter, from the day each filing was public, returned +15.4% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: -3.6% against +20.1%. Over 5 years: +7.0% a year against +11.6%.
When is Finepoint Capital LP's next 13F filing due?
13F filings are due 45 days after each quarter ends. Finepoint Capital LP's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.
How much money does Finepoint Capital LP manage?
Finepoint Capital LP reported $5.0B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $461.0M.